Conversion From Intravenous Alteplase to Tenecteplase for Treatment of Acute Ischemic Stroke Across a Large Community Hospital Health System.

Erika DittmarThomas WolfelLourdes MenendezJessilyn PozoMaygret RamirezStarlie C BelnapF D L R La Rosa

Published in: The Annals of pharmacotherapy (2023)

Conversion from alteplase to tenecteplase can be safely and effectively achieved at a large community hospital health system with differing levels of stroke certification. There were also additional cost savings and practical advantages including workflow benefits.

Keyphrases

acute ischemic stroke
healthcare
mental health
acute care
atrial fibrillation
adverse drug
high dose
electronic health record
low dose
combination therapy
blood brain barrier
replacement therapy